P
atients with inflammatory bowel disease (IBD) suffer from chronic and often progressive bowel injury and have a high rate of morbidity and disability. Current treatment strategies include chronic maintenance medical therapy, and many patients will require hospitalization or surgery in their lifetime. [1] [2] [3] IBD is an expensive disease because of direct costs of care and indirect costs associated with disability and missed work and school. [3] [4] [5] [6] [7] Although much is known about the cost of caring for patients with IBD, 4, [8] [9] [10] [11] there are no data regarding access to health care resources in this population.
One mechanism for obtaining this information is the Centers for Disease Control National Health Interview Survey (NHIS), a well-described and validated survey instrument used to observe population trends in U.S. health care-related issues, including access to care. 12 Previous studies have used the NHIS to examine health care utilization within specific populations in the United States, [13] [14] [15] [16] although none have been conducted in relation to the IBD population.
Using the NHIS as a model, we sought to provide a national snapshot of the current status of care for patients with IBD regarding access to care, access to specific therapies, timeliness of care, affordability of care, and financial stress related to care.
METHODS

Survey Development
We modified the National Health Interview Survey to develop a 59-item survey for patients with IBD. Additional questions were added to solicit IBD-specific information, such as respondent disease type, disease severity, and IBD-related treatments. Questions focused on the 12 months before participation and included topics such as employment and insurance status, access to provider care, strategies to afford care, as well as participant-reported therapy, and outcomes. The survey was then transferred to SurveyMonkey (Palo Alto, CA) with appropriate question skip logic to exclude non-IBD individuals and to allow for appropriate follow-up questions. After drafting the web-based survey, it was piloted with voluntary patients with IBD, and underwent 2 subsequent revisions based on feedback (see Appendix, Supplemental Digital Content 1, http://links.lww. com/IBD/B421).
Survey Delivery
The survey was delivered through electronic mail (email) blast by the Crohn's and Colitis Foundation of America (CCFA) to their email database of 457,037 email addresses. The database included patients, providers, industry personnel, and donors; however, the survey aimed to solicit responses from only patients through the use of an initial screening question targeting responses from patients with IBD. The survey link was also posted to the CCFA Website and Facebook pages. Two subsequent waves of email announcements were sent during a 3-week period in March and April 2013. This methodology yielded a convenience sample from the CCFA network.
Statistical Analysis
Data from all respondents were transferred into a MySQL (ORACLE, Redwood Shores, CA) relational database. Microsoft Excel (Redmond, WA) and IBM SPSS Inc. version 23 (IBM, Armonk, NY) were used for analyses. Internet protocol (IP) addresses were compared with rule out duplicate responses from the same respondent. Only respondents with IBD who resided within the U.S. were included in the final data set. Analysis of data and subset analyses were performed using IBM SPSS Inc. version 23 (Chicago, IL) and used analysis of variance, binary logistic regression, independent-sample t tests, and Mann--Whitney U test. To account for multiple comparisons, all analyses (unless explicitly stated otherwise) are significant at the 0.002 level, which is the critical P value (a) after adjusting for the total number of statistical tests included in this study according to the Bonferroni correction.
Binary logistic regression was used to estimate the probability of a response based on independent variables. Binary logistic regression was used rather than linear regression when the independent variable was categorical and the dependent variable was dichotomous, such as if the respondent had or had not delayed medical care in the last 12 months. Independent-sample t tests were performed with continuous variables and were 2-tailed. Analysis of variance was used to compare for differences between multiple groups, for example with educational attainment. Mann-Whitney U test was used with categorical variables.
Geolocation of Participants: IP Addresses
Survey participants' country residence was determined using a geolocation script written in Python (2.7). The GeoIP (1.3.2) package for Python was provided by MaxMind (Waltham, MA) under GNU public license. Country of residence was resolved from IP Internet Protocol v4 addresses (IPv4) addresses. Only the U.S. participants were included in the data analysis. IP addresses were separated from survey responses and not used in further analyses and were discarded.
Ethical Considerations
Given our study's intention for needs assessment and quality assessment, low risk to patients, and survey methodology, it was not submitted for local institutional review board approval. The survey was completed anonymously, as the authors did not collect email or login information and do not have sufficient data to identify individuals by IP addresses. Survey respondents younger than 18 years of age were not included in these analyses.
RESULTS
Population
Of the 457,037 email recipients sent the survey, 82,613 (18%) opened the email, 13,780 forwarded the email, and 5450 individuals clicked through to the survey. Seventy percent of those who clicked through also completed the survey (69.8%, n ¼ 3802). Of those, 3646 (67%) respondents within the United States and reported a diagnosis of IBD completed the survey, including 3608 individuals who were 18 or older. Participants were removed from the data set if they did not have IBD (n ¼ 422), were younger than 18 years of age (n ¼ 38), or resided outside the United States, determined by IP geolocation (n ¼ 156) (Fig. 1) .
Most respondents were Crohn's disease patients (64.8%, n ¼ 2231) rather than ulcerative colitis (32.0%, n ¼ 1102) with 2.9% reporting indeterminate disease (n ¼ 101). The median age of respondents was 44.8 years (range 18-86 years; SD 15.2 years). Most respondents obtained college or graduate-level educational degrees, with highest level of education as follows: 1.6% (n ¼ 54) completed less than high school, 8.0% (n ¼ 267) with high school degree or equivalent, 27.1% (n ¼ 903) some college, 29.9% (n ¼ 996) completed a college degree, 6.8% (n ¼ 226) with some graduate-level work, and 26.5% (n ¼ 883) with a graduate or professional degree.
Most respondents were women (72.2% n ¼ 2382) with the distribution of Crohn's disease and ulcerative colitis between sexes being approximately equal. Many respondents reported long disease duration: 36.4% (n ¼ 1315) indicating at least 15 years since the onset of disease (Table 1) .
Employment Status
When asked about employment status, 64.4% (n ¼ 2154) of respondents reported working for pay. Seventeen percent (17.4%, n ¼ 584) reported not working at a job or business and not looking for work, and an additional 10.0% (n ¼ 334) reported being unemployed but actively looking for employment (Table 1) . Thirty-seven individuals noted being employed, but unable to work because of health reasons and 8 individuals indicated they are employed but not working because of disability (Table 1) . Of note, students were not restricted from answering this question. Employment status was associated with education level. A separate question obtained further information on the respondent's current work status, asking if respondents were currently working full time 51.4% (n ¼ 1695), part time 12.5% (n ¼ 412) at home/as a student 7.5% (n ¼ 246).
Care Team
Respondents who reported having a primary care provider (PCP) were 93.2% (n ¼ 3332). Of those who identified a PCP, 40.6% (n ¼ 1340) have a family practitioner, 31.7% (n ¼ 1047) have an internist/general pediatrician, and 24.8% (n ¼ 819) identified their gastroenterologist as their PCP. Logistic regressions predicting whether or not a respondent identified their gastroenterologist as their PCP revealed several predictive demographic factors including sex b ¼ 0.4, t(1) ¼ 20.9, P , 0.001, age group b ¼ 0.1, t(1) ¼ 11.4, P ¼ 0.001, and education b ¼ 0.2, t(1) ¼ 30.6, P , 0.001. The odds that a man in our sample viewed his gastroenterologist as his PCP were 0.659 times the odds of a woman viewing her gastroenterologist as her PCP. Other groups more likely to view their gastroenterologist as their PCP included respondents younger than 40 (25.8%, n ¼ 315), those with a high school degree (34.1%, n ¼ 84), or some college (27.1%, n ¼ 227), as opposed to respondents older than 40 (21.3%, n ¼ 376) and those with graduate or professional degrees (18.5%, n ¼ 151). A total of 6.8% (n ¼ 243) of respondents have no PCP. Of the individuals without a PCP, 48.6% (n ¼ 118) received care from a clinic or health center without a specific provider, whereas 28.0% (n ¼ 68) reported they did not receive primary care and did not get general health care. Of respondents without a PCP, factors limiting access were reported, which included prohibitive cost (22.6%, n ¼ 55), belief they did not require a doctor (22.2%, n ¼ 54), doctors unavailable or had moved from their practice (17.7%, n ¼ 43), or lack of knowledge about where to receive care (13.6%, n ¼ 33). When asked about their IBD care, 86.9% (n ¼ 3137) of respondents report that a gastroenterologist manages their IBD, and 57.6% (n ¼ 2079) noted that they believe their gastroenterologist is an IBD specialist.
Health and Life Insurance
The majority of respondents (96.1%, n ¼ 3148) report having some health insurance coverage. Compared with 12 months before this survey, most (62.9%, n ¼ 2270) individuals indicated their insurance coverage remained about the same. Twenty-one percent (21.1%, n ¼ 762) stated their insurance coverage is worse than a year ago, whereas 7.4% (n ¼ 267) reported their coverage was better.
Of survey respondents who tried to purchase insurance in the last 3 years (n ¼ 452, 12.5% of the sample), 81.0% (n ¼ 364) said it was somewhat difficult or very difficult to find adequate coverage and 88.9% (n ¼ 400) said it was somewhat difficult or very difficult to afford (Fig. 2) . Over half of the IBD respondents had been turned down by an insurance company (55.3%, n ¼ 250) and were charged a higher price because of their own or their family's health (51.8%, n ¼ 234). IBD respondents who had specific health conditions excluded from their coverage were 42.5% (n ¼ 192). Respondents who reported a need to purchase secondary insurance were 12.1% (n ¼ 438). Of those who required secondary coverage, 63.0% (n ¼ 276) said the primary insurance did not provide adequate coverage. Almost a third (28.3%, n ¼ 124) said medications were too expensive, and one of the 6 (16.7%, n ¼ 73) reported the copay was too expensive.
These challenges were not exclusive to health care insurance. When asked about purchasing life insurance, 11.4% (n ¼ 413) of the total survey respondents reported buying life insurance over the past year. Of the respondents who did not buy life insurance (n ¼ 2856), one-sixth (15.9%, n ¼ 453) did not buy life insurance because it was too expensive, whereas 9.5% (n ¼ 270) reported they were turned down because of a preexisting condition.
Financial Concerns
The survey identified widespread financial concerns surrounding respondents' IBD care. Regardless of health insurance status, 21.9% (n ¼ 763) would be very worried, and 44.4% (n ¼ 1551) would become somewhat worried about paying medical bills if they become ill.
Impact of Access on Health
Respondents identified several factors related to access to care and cost of care that impact their health. One of the 4 survey respondents (25.4%; n ¼ 897) reported delayed medical care in the past 12 months, with half of these (48.0%, n ¼ 431) reporting the delay was due to the cost of care (Table 2) . Indeed, respondents delaying therapy was significantly associated with health care-related financial worry, through chi-square test (N ¼ 3477, x 2 ¼ 2362.2, P , 0.001). Other common reasons people delayed care included being unable to get an appointment soon enough (31.7%, n ¼ 284) and not enough time due to scheduling priorities (31.8%, n ¼ 285).
Many respondents reported that they needed a service, but could not afford it, including purchasing prescription medication (76.5% of respondents who delayed health care, 19.0% of the total respondents; n ¼ 686), dental care (74.6% of respondents who delayed health care, 18.5% of total respondents, n ¼ 669), eye care (53.5% of respondents who delayed health care, 13.3% of total respondents, n ¼ 480), specialist care (43.5% of respondents who delayed health care, 10.8% of total respondents, n ¼ 390), and follow-up care (32.0% of those who delayed care, 8.0% of total respondents; n ¼ 287). A small percentage of respondents reported that they delayed having surgery (10.5% of those who delayed care and 2.6% of total respondents, n ¼ 94). Similarly, of the respondents who reported not having a usual source of general medical care or PCP, the most common reason was that it was too expensive or they were without insurance (22.6%, n ¼ 55). Eleven percent of survey respondents had been recommended a medical therapy they could not get because of insurance status (11.8%, n ¼ 426). Of the 1260 respondents who reported seeking ways to save money for their health care in the last year, they delayed an appointment with a health care provider (47.3%, n ¼ 596), asked their doctor for a lower cost medication (41.6%, n ¼ 524), delayed filling a prescription (35.3%, n ¼ 445), and declined or delayed a medical test (34.9%, n ¼ 440). They additionally reported taking less medication (29.8%, n ¼ 375) and skipping medication doses (25.2%, n ¼ 317). (Table 3) .
Respondent demographic characteristics were analyzed by 1-way analysis of variance to identify an at-risk group for health care-related financial worry, access to insurance, and delayed medical care. Respondent characteristics that significantly contributed to the variance of worry about medical bills include IBD severity (self-report of what their physician labeled their severity to be), IBD symptom control, age, sex, insurance type, education, income, marital status, work status, and employment which each contributed to the variance with P , 0.001. More specifically, demographic factors included age (F (1,3200) Younger respondents tended to have greater worry; respondents younger than 40 reported significantly more worry than respondents older than 40 by Mann-Whitney U test (U ¼ 1,180,503.5, P ¼ 0.005). Female respondents reported more worry than male respondents (U ¼ 949,595.5, P , 0.001). Insurance type also significantly contributed to the variance of health care-related financial worry, with those with no insurance being the most worried (quantified on a 3-point scale with 1 being "very worried" and 3 being "not worried at all," mean 1.12, SD ¼ 0.3), and selfinsured being the next most worried (mean 1.88, SD ¼ 0.6). Additional factors which significantly contributed to the variance included IBD severity (as measured by respondents reporting of their physician-ranked severity) (F (2,3060) ¼ 31.7, P , 0.001) and IBD symptom control (as measured by respondent report of their symptom control over the past year) (F (3,3347) ¼ 74.2, P , 0.001).
Several respondent characteristics were significantly associated with difficulties with insurance coverage and affordability including age (F (1,426) ¼ 28.4, P , 0.001), IBD disease control (F (3,441) ¼ 6.1, P , 0.001), income (F (6,431) ¼ 2.6, P ¼ 0.017), and work status (F (5,438) ¼ 6.5, P , 0.001). Respondents with greater difficulty obtaining insurance coverage were younger, reported more frequent IBD symptoms, reported lower income, and identified themselves as disabled or not currently working.
Respondent demographic factors that predicted delayed medical care by binary logistic regression included self-reported IBD severity b ¼ 20.3, t(1) ¼ 18.8 (P , 0.001), presence of a recent flare b ¼ 0.9, t(1) ¼ 94.6 (P , 0.001), age range b ¼ 0.2, t(1) ¼ 54.9 (P , 0.001), income b ¼ 0.2, t(1) ¼ 119.8 (P , 0.001), and insurance type b ¼ 20.2, t(1) ¼ 88.8 (P , 0.001). Respondents most likely to delay medical care reported more severe IBD, reported a flare in the past 12 months, were aged 21 to 30 years or 41 to 50 years, lower income and had either no insurance, insurance through a school's plan, or were self-insured. Respondents who delayed getting health care were 2.5 times more likely to have reported an IBD flare in the past year (95% confidence interval 2.1-3.0, P , 0.001).
Emergency Department (ED) Utilization
Based on the hypotheses that lack of access and lack of a PCP may result in more resource utilization, we assessed respondent characteristics associated with ED visits and determined 32.3% (n ¼ 1076) of the total survey respondents had visited an ED in the past 12 months; 15.4% (n ¼ 519) once in Demographics associated with ED visits included Crohn's disease diagnosis (U ¼ 995,045.5, P , 0.001), age ,40 (U ¼ 1,119,686.5, P , 0.001), female sex (U ¼ 1,018,860.0, P ¼ 0.001), lack of health insurance (U ¼ 168,714.5, P ¼ 0.001), income ,$50,000 (U ¼ 649,109.5, P , 0.001), non-White race (U ¼ 374,084.5, P ¼ 0.003), and current use of steroids (U ¼ 565,554.0, P , 0.001). Whether or not, the respondent identified having a PCP was not significantly associated with the number of ER visits in the last year (U ¼ 349.574.5, P ¼ 0.851). However, if the respondent identified a gastroenterologist as their PCP, it was significantly associated with more ED visits (U ¼ 848,491.0, P ¼ 0.024).
Resources to Overcome Barriers
Respondents identified several resources used to overcome barriers in access to care. Seventy-five percent (n ¼ 2708) of survey respondents used their computer to look up information related to their IBD, and 26.5% (n ¼ 957) used on-line chat groups/forums to learn about their IBD.
Respondents are also using computers to manage health care, such as filling a prescription (31.8%, n ¼ 1149), communicating with their gastroenterologist/nurse/other health care team member (20.5%, n ¼ 741), and schedule appointments with their gastroenterologist (9.0%, n ¼ 325).
DISCUSSION
This is the first assessment of U.S. IBD patient health care access, using a modified version of the U.S. Centers for Disease Control and Prevention National Health Interview Survey, which reveals that a large number of patients have health care-related financial worry and have forgone a variety of medical services because of cost, lack of prompt access to care, and worry over medical coverage.
The current access to care seems tenuous, given the significant percentages of patients who report difficulty obtaining sufficient insurance coverage, with over half of patients who had tried to purchase insurance recently reporting they were turned down by an insurance company. Those who were able to purchase insurance frequently reported being charged a higher price because of their own/their family's health or having specific health conditions which were excluded from their coverage. Even patients with insurance were worried about cost, coverage for future potential expensive care, such as hospitalization, and more expensive medications. This lack of adequate coverage and widespread worry about future cost and affordability of care during illness had substantial consequences, with over 25% of respondents reporting that they had forgone therapy. Forgoing therapy included skipping medication doses to save money, choosing different medications than those recommended, not using specialist care, and skipping non-IBD care, such as basic dental care.
Other interesting findings include that the gastroenterologist was identified by respondents to be the PCP for over a quarter of patients, with a similar percentage reporting that they do not receive any general health care. Gastroenterologists are trained in internal medicine, and some may chose to additionally serve as patients' PCPs. However, it is possible many gastroenterologists may not be aware that their patients are viewing them in this role and would adjust their care if they knew this fact. If patients are using their gastroenterologist as a PCP, then the gastroenterologist should be aware of this role and accept responsibility for routine screening, health maintenance of other chronic diseases, and other primary care tasks. Alternatively, the gastroenterologist may chose to recommend the patient seek concomitant primary care from another physician. This finding may be due to the younger age of the IBD patient population and lack of perceived need for additional care providers (i.e., patient choice) or may be due to lack of access or lack of a recommendation from the gastroenterologist to identify an appropriate PCP.
It is also of great interest that most of the respondents indicated that their gastroenterologist specialized in IBD. We intentionally did not define what an "IBD specialist" is in the survey, to assess whether the patient viewed their doctor as a specialist. We did not think we could assess whether they knew if their physician actually obtained additional training in advanced IBD or whether they were considered by the profession as an "IBD expert." In fact, no such established definition exists, and it is possible that many patients may not be aware of the existence of IBD subspecialists. The large number of patients who stated that they are seeing an IBD specialist may also be a reflection of the biased population of people who responded to this CCFAsponsored survey (e.g., that they actually do see physicians with additional training and expertise in IBD). The implication of this finding is that patients may not be aware of the existence of gastroenterologists with additional training and specialization in IBD, and may not know to consider care elsewhere if they are not achieving sufficient disease control or quality of life. As the care of patients with IBD becomes more complex, there may be a role for defining requirements to be considered an "IBD expert."
We were able to identify variables most associated with lack of health care access in this IBD population. Patients most likely to lack adequate insurance coverage, worry over medical coverage, and forgo medical services were found to be those with the most severe IBD symptoms and recent flares, as well as demographic variables such as age, education, income, and work status. We define an at-risk group of patients with IBD who have inadequate health care access and associated disability, active IBD symptoms, and delays and deficiencies in their receipt of care.
Ongoing and future interventions should target this group of higher-risk patients.
Using these survey data, we identified risk factors for ED utilization, including Crohn's disease, age ,40, female sex, lower income, non-White race, and steroid therapy. Patients within their first year of diagnosis also reported increased ED visits which has been demonstrated to be more expensive than primary care and preventive care. 17 Identifying these at-risk groups may provide information for providers who can develop interventions that may reduce the ED visits of such so-called "high utilizers" through preventive care and other interventions. This is certainly an area for future investigation and of great interest to patients, providers, and payers.
The limitations of this study include the limitations inherent in self-report survey data, including reliance on respondents to provide accurate, bias-free responses, and the inability to determine cause and effect. This is particularly influential in questions surrounding disease severity, health care-related financial worry, and other questions that allow personal interpretation. However, the aim of this survey was to assess patients' perception of access to care and health care behaviors; thus the self-report survey data are a reasonable, though imperfect, methodology. Additionally, this is a cross section as opposed to longitudinal survey, limiting analysis from assessing changes in individual responses over time. Furthermore, the original NHIS was conducted as an interview, and this study was conducted as a survey, which admittedly may result in additional inaccuracies. The instrument was not validated after the changes to the original Centers for Disease Control survey to specifically address patients with IBD. However, extensive testing and evaluation were performed before survey release to attempt to address concerns regarding the use of this novel instrument.
Lastly, there is potential bias using the CCFA database and an internet survey tool, although we did not specifically inquire whether respondents were active CCFA members (at the time of the survey in 2013, the lay/patient membership of the CCFA was 6548). The email with the survey asked that only people with IBD complete the survey, and any respondents without IBD were excluded from the data set. Because the CCFA listserv contains people without IBD, such as providers, donors, and other industry professionals, it is impossible to calculate an accurate response rate for this survey. The large number of click-throughs and completion rates of those who did open the email, however, is notable and reassuring. However, there is potential bias in the analyzed population toward those individuals who are more likely to respond to outreach such as this, are English-speaking, are networked with patient advocacy groups, and those who are more internet-savvy, although we point out the relative ubiquitousness of email and electronic communication in today's society. It is additionally possible that people with a higher disease burden would be more likely to answer the survey. The demographics of survey participants are not representative of the general U. S. population, as demonstrated by their high educational attainment and only 28.8% reporting an annual income of $50,000 or less.
Although an internet survey methodology was chosen for the ability to distribute the survey widely and obtain a diverse sample, the demographics above indicate this sample is not representative of the U.S. population.
Assessment of IBD patients' health care needs has become more important since signing of the Patient Protection and Affordable Care Act (PPACA, commonly called "the Affordable Care Act" or ACA) in 2010 and its activation on January 1, 2014 (after our survey was completed). This legislation has components which were designed to improve access and affordability of care for persons with chronic conditions, including the following stipulations: (1) no lifetime or annual limits on cost of care; (2) extension of dependent coverage to age 26; (3) no insurance company exclusion for pre-existing conditions; (4) fair premiums/value for the dollar. 17, 18 Additionally, although the ACA focuses on affordable preventative care, explicit measures have also been established for chronic conditions with the intention of keeping patients with chronic conditions healthier. 18, 19 However, little is known about the impact of this Act on patients with chronic conditions, specifically IBD. Now that this initial survey has been completed, we are ready for a "post-ACA" survey to assess whether there has been a change in access and refine and focus on additional needs of this important patient group. The follow-up survey can further assess for impacts of state-to-state variability in ACA implementation, such as whether or not states implemented Medicaid expansion.
SUMMARY AND CONCLUSIONS
In summary, this survey provides a view into the health care behaviors and access to care of a large nationwide sample of patients with IBD. It is concerning that participants reported delayed or avoidance of health care because of cost, as well as the high prevalence of worry about health care costs regardless of insurance status. Many respondents report difficulty obtaining sufficient insurance coverage, with over half of respondents who had tried to purchase insurance recently reporting they were turned down by an insurance company. We identified higher-risk groups for poor access and for ED utilization, including those respondents with lower socioeconomic status, Crohn's disease patients, and younger patients (age ,40). These data should be considered in developing tailored policy, as well as educational and medical interventions aimed at decreasing barriers to care and may be particularly useful in advocating to reduce health disparities.
